HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Emitefur

structure given in first source
Also Known As:
3 (3-(6-benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-1-ethoxymethyl-5-fluorouracil; BOF A2; BOF-A2; Benzoic acid, 3-((3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)carbonyl)-, 6-(benzoyloxy)-3-cyano-2-pyridinyl ester
Networked: 22 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kindler, H L: 1 article (08/2001)
2. Eng, C: 1 article (08/2001)
3. Schilsky, R L: 1 article (08/2001)
4. Eager, R: 1 article (10/2000)
5. Tkaczuk, K: 1 article (10/2000)
6. Pazdur, R: 1 article (10/2000)
7. Thompson, J: 1 article (10/2000)
8. Sekar, K: 1 article (10/2000)
9. Nemunaitis, J: 1 article (10/2000)
10. Hoff, P M: 1 article (10/2000)

Related Diseases

1. Stomach Neoplasms (Stomach Cancer)
2. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Neoplasms (Cancer)
5. Yoshida Sarcoma

Related Drugs and Biologics

1. Fluorouracil (Carac)
2. Uracil
3. Tegafur
4. Prodrugs
5. Leucovorin (Folinic Acid)
6. capecitabine (Xeloda)
7. Emitefur
8. 2,6-dihydroxy-3-cyanopyridine
9. 1-ethoxymethyl-5-fluorouracil
10. irinotecan (Camptosar)

Related Therapies and Procedures

1. Oral Administration
2. Adjuvant Chemotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Combination Drug Therapy (Combination Chemotherapy)
5. Drug Therapy (Chemotherapy)